Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Raskin

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|December 24, 2005
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesDavid M Nathan, Patricia A Cleary, Jye-Yu C Backlund, et al.
Circulation|August 19, 2007
Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy studyJonathan M McGavock, Ildiko Lingvay, Ivana Zib, et al.
Diabetes Care|August 28, 2003
Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week studyPhilip Raskin, Bruce W Bode, Jennifer B Marks, et al.
Diabetes|June 14, 2013
Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications studyTrevor J Orchard, Wanjie Sun, Patricia A Cleary, et al.
Journal of Diabetes and Its Complications|March 5, 2005
The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trialGeorge L Bakris, David S H Bell, Vivian Fonseca, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 13, 2014
Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task forceGeorge Grunberger, Jill M Abelseth, Timothy S Bailey, et al.
Diabetes Care|December 13, 2022
Retinopathy During the First 5 Years of Type 1 Diabetes and Subsequent Risk of Advanced RetinopathyJohn I Malone, Xiaoyu Gao, Gayle M Lorenzi, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetesBerrin Ergun-Longmire, John Marker, Adina Zeidler, et al.
Diabetes Care|November 20, 2025
Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 DiabetesTimothy E Graham, Dan Raghinaru, Samina Afreen, et al.
Diabetes Technology & Therapeutics|July 8, 2011
Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter studyNancy Bohannon, Richard Bergenstal, Robert Cuddihy, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|December 24, 2005
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesDavid M Nathan, Patricia A Cleary, Jye-Yu C Backlund, et al.
Circulation|August 19, 2007
Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy studyJonathan M McGavock, Ildiko Lingvay, Ivana Zib, et al.
Diabetes Care|August 28, 2003
Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week studyPhilip Raskin, Bruce W Bode, Jennifer B Marks, et al.
Diabetes|June 14, 2013
Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications studyTrevor J Orchard, Wanjie Sun, Patricia A Cleary, et al.
Journal of Diabetes and Its Complications|March 5, 2005
The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trialGeorge L Bakris, David S H Bell, Vivian Fonseca, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 13, 2014
Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task forceGeorge Grunberger, Jill M Abelseth, Timothy S Bailey, et al.
Diabetes Care|December 13, 2022
Retinopathy During the First 5 Years of Type 1 Diabetes and Subsequent Risk of Advanced RetinopathyJohn I Malone, Xiaoyu Gao, Gayle M Lorenzi, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetesBerrin Ergun-Longmire, John Marker, Adina Zeidler, et al.
Diabetes Care|November 20, 2025
Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 DiabetesTimothy E Graham, Dan Raghinaru, Samina Afreen, et al.
Diabetes Technology & Therapeutics|July 8, 2011
Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter studyNancy Bohannon, Richard Bergenstal, Robert Cuddihy, et al.
Pageof 13